BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35326884)

  • 1. Mechanisms of Action of Carbapenem Resistance.
    Aurilio C; Sansone P; Barbarisi M; Pota V; Giaccari LG; Coppolino F; Barbarisi A; Passavanti MB; Pace MC
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MULTIRESISTANT BACTERIA].
    Bedenić B; Sardelić S; Ladavac M
    Acta Med Croatica; 2015 Sep; 69(3):211-6. PubMed ID: 29077379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class D β-lactamases: a reappraisal after five decades.
    Leonard DA; Bonomo RA; Powers RA
    Acc Chem Res; 2013 Nov; 46(11):2407-15. PubMed ID: 23902256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The KPC type beta-lactamases: new enzymes that confer resistance to carbapenems in Gram-negative bacilli.
    Sacha P; Ostas A; Jaworowska J; Wieczorek P; Ojdana D; Ratajczak J; Tryniszewska E
    Folia Histochem Cytobiol; 2009; 47(4):537-43. PubMed ID: 20430717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to beta-lactam antibiotics.
    Livermore DM
    Scand J Infect Dis Suppl; 1991; 78():7-16. PubMed ID: 1947825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
    Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded Substrate Activity of OXA-24/40 in Carbapenem-Resistant Acinetobacter baumannii Involves Enhanced Binding Loop Flexibility.
    Staude MW; Leonard DA; Peng JW
    Biochemistry; 2016 Nov; 55(47):6535-6544. PubMed ID: 27783477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudomonas aeruginosa--a significant hospital pathogen and resistance to carbapenem].
    Kucisec-Tepes N
    Acta Med Croatica; 2004; 58(4):313-21. PubMed ID: 15700688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections.
    Bush K
    Crit Care; 2010; 14(3):224. PubMed ID: 20594363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
    Martínez-Martínez L; González-López JJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia.
    Vargas-Alzate CA; Higuita-Gutiérrez LF; Jiménez-Quiceno JN
    Biomedica; 2019 May; 39(s1):35-49. PubMed ID: 31529847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic inactivation of bacterial carbapenemases restores bacterial carbapenem susceptibility and enhances carbapenem antibiotic effectiveness.
    Feng Y; Palanisami A; Ashraf S; Bhayana B; Hasan T
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101693. PubMed ID: 32173586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial resistance to carbapenems.
    Livermore DM
    Adv Exp Med Biol; 1995; 390():25-47. PubMed ID: 8718600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review.
    Katale BZ; Misinzo G; Mshana SE; Chiyangi H; Campino S; Clark TG; Good L; Rweyemamu MM; Matee MI
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):127. PubMed ID: 32762743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding the Structural Basis For Carbapenem Hydrolysis By Class A β-lactamases: Fishing For A Pharmacophore.
    Tondi D; Cross S; Venturelli A; Costi MP; Cruciani G; Spyrakis F
    Curr Drug Targets; 2016; 17(9):983-1005. PubMed ID: 26424401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.
    Spera AM; Esposito S; Pagliano P
    Infez Med; 2019 Dec; 27(4):357-364. PubMed ID: 31846984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.